Who owns TRAVERE THERAPEUTICS INC (TVTX?
- CUSIP Number: 89422gaa5
Tip: Access positions for across all investors
Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Travere Therapeutics stock
Who bought or sold TRAVERE THERAPEUTICS INC (TVTX this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wolverine Asset Management | 45M | $39M | 0% | Sep 2024 |
|
| D. E. Shaw & Co | 42M | $36M | 0% | Sep 2024 |
|
| Oaktree Capital Management | 30M | $26M | 100% | Sep 2024 |
|
| Graham Capital Management | 16M | $13M | 100% | Sep 2024 |
|
| Silverback Asset Management | 13M | $11B | -12% | Sep 2024 |
|
| Capstone Investment Advisors | 11M | $9.8M | -41% | Sep 2024 |
|
| Highbridge Capital Management | 10M | $8.6M | -70% | Sep 2024 |
|
| CNH Partners | 9.5M | $8.2M | -5% | Sep 2024 |
|
| Point72 Asset Management | 8.5M | $7.4M | 89% | Sep 2024 |
|
| Lazard Asset Management | 8.0M | $6.9M | -74% | Sep 2024 |
|
| Readystate Asset Management | 5.0M | $4.3M | -38% | Sep 2024 |
|
| Affinity Asset Advisors | 5.0M | $4.3M | 100% | Sep 2024 |
|
| Agf Management | 4.5M | $3.9M | 20% | Sep 2024 |
|
| Advent Capital Management | 3.9M | $3.4M | 100% | Sep 2024 |
|
| BlackRock | 3.7M | $2.4M | 16% | Jun 2024 |
|
| Aequim Alternative Investments | 3.6M | $3.1M | 100% | Sep 2024 |
|
| CSS | 3.5M | $3.0M | 250% | Sep 2024 |
|
| BlackRock | 2.7M | $2.3M | 100% | Sep 2024 |
|
| Jane Street | 2.6M | $2.3M | -7% | Sep 2024 |
|
| DeepCurrents Investment Group | 2.0M | $1.3M | 100% | Jun 2024 |
|
| Jpmorgan Chase & Co | 900k | $777k | 100% | Sep 2024 |
|
| Verition Fund Management | 602k | $392k | 100% | Jun 2024 |
|
| Nomura Holdings | 147k | $2.1M | -75% | Sep 2024 |
|
| Context Capital Management | 57k | $49M | -6% | Sep 2024 |
|
| SG Americas Securities | 16k | $1.4M | 100% | Sep 2024 |
|
Who sold out of Travere Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Aviva | Mar 2024 | 20M | $13M |
| Morgan Stanley | Mar 2024 | 2.6M | $1.6M |
| Lion Point Capital | Mar 2024 | 1.0M | $630k |